ライフサイエンスコーパス: mean age

1 years, 50.4% male, and 110 HIV- adolescents, mean age 11.8 (SD, 1.8) years, 45.6% male, were tested a

2 Results Images from 19 patients (mean age, 11 years +/- 5 [standard deviation]; 10 female

3 Five hundred fifteen HIV+ adolescents, mean age 12 (standard deviation [SD], 1.6) years, 50.4%

4 1 male) were in the control group, and nine (mean age, 12 years +/- 6; four male) were in the subgrou

5 ears, SD) and 54% were wheelchair-dependent (mean age: 13.4 +/- 9.8 years, SD).

6 in the ferumoxytol-exposed (case) group, 21 (mean age, 14 years +/- 5; 11 male) were in the control g

7 ]; 66 boys) and in 105 control participants (mean age, 14.6 years +/- 0.5; 59 boys) were evaluated.

8 teral knee MRI scans obtained in 105 skiers (mean age, 14.8 years +/- 0.6 [standard deviation]; 66 bo

9 Results A total of 314 patients (mean age, 14.9 years; age range, 2-18 years; 28 prepuber

10 In this study, among 110 young children (mean age, 18 months) with linear growth stunting who wer

11 from 42 patients with infantile nystagmus of mean age 19.8 months (range, 0.9-33.4 months; standard d

12 The participants were young adults (n=525; mean age 21.5 +/- 3.0 years; mean BMI of 20.7 +/- 2.7kg/

13 prospective exploratory study, 10 patients (mean age, 21 years; age range, 5-58 years; five men) and

14 in the Kutupalong-Balukhali Expansion Site (mean age, 21 years; standard deviation [SD], 18 years; 5

15 20,21) were recorded as eighty young adults (mean age, 21.7 years) performed a goal-directed episodic

16 females) and neurotypical controls (n = 24, mean age 22, 8 females) during fMRI scanning.

17 ited to the intervention group (316 [49.6%], mean age 22.7 years [SD 5.7]) or the control group (320

18 dition, TRIAD included healthy young adults (mean age 23 years) and BioFINDER-2 included patients wit

19 with autism spectrum disorders (ASD; n = 24, mean age 23 years, 8 females) and neurotypical controls

20 9 years) and 113 control subjects (64 women, mean age 23.5 +/- 8.4 years).

21 lable on 543 and 213 patients, respectively (mean age 25.4 +/- 6.6 years).

22 ve men) and 10 healthy control participants (mean age, 25 years; age range, 10-39 years; five men) un

23 Bilateral LLRs of 255 patients (mean age, 26 years +/- 23 [standard deviation]; range, 0

24 In this study of 55 males (mean age 27 years) with classic Fabry disease genotype a

25 Of the 1624 women randomized (mean age, 30.4 years, mean body mass index, 39.5), 1608

26 49.6 years) and 50 healthy control subjects (mean age 31.3 years) were examined.

27 7 cases were included (28 boys and 19 girls; mean age, 31 days).

28 s problem, ten healthy US military veterans (mean age = 32.6 years +/- 6.11; 1 female) completed a ph

29 e male-to-female transgender (MtF) identity [mean age: 32.3 (18; 61)] than in the male control group

30 , 2016, 439 (42%) of 1047 assessed patients (mean age 33 years; 363 [83%] men) were randomly assigned

31 Twenty healthy participants (mean age, 33 years +/- 5; 16 men) underwent a simulation

32 of 437 eyes from 235 patients were included (mean age, 33.8 +/- 15.1 years; 55.3% female).

33 Results A total of 128 children (mean age, 33.9 months +/- 1.8 [standard deviation]; 59 g

34 At inclusion, CD subjects were younger (mean age 34.2 versus 39.8 years; p < 0.0001) and had bet

35 iduals with chronic schizophrenia (48 women, mean age 34.7 +/- 12.9 years) and 113 control subjects (

36 .3 (18; 61)] than in the male control group [mean age: 34.5 (18; 65)] with a Cohen's d = 0.271.

37 Of the 400 randomized participants (mean age, 35 years; 199 [50%] women), 393 (98%) complete

38 V co-infected females presented at a younger mean age (36.8 years) than HBV mono-infected women (50.5

39 Results MRI scans from 1008 participants (mean age, 37.7 years +/- 9.7; 730 women) were analyzed.

40 with ASD) scanned at up to four time points (mean ages = 38, 50, 64, and 137 months, respectively) an

41 ons) and a normal database of 2027 patients (mean age, 38 years +/- 24; 1088 female patients) were us

42 Nineteen consecutive patients (84% males; mean age 39+/-15 years [range, 20-76 years]) were includ

43 ith ASD) scanned at up to three time points (mean ages = 39, 53, and 65 months, respectively) using m

44 Methods: Ten patients with a peripheral AVM (mean age, 40 y; 4 men and 6 women) and scheduled for end

45 0 patients with definite ARVC were enrolled (mean age 42 +/- 17 years, 97 males) in this multicenter

46 A total of 105 eyes from 105 subjects (mean age, 42.1 +/- 13.9 years; range, 18-65) were includ

47 ited the emergency department, 181 subjects (mean age, 43.0; 44% male) were diagnosed with anaphylaxi

48 28 age-matched healthy control participants (mean age, 44 years +/- 13; 16 women) were evaluated.

49 sease [CD], 13 with ulcerative colitis [UC], mean age 45 years [range 19-90], 7 female), and 20 patie

50 Results Eleven astronauts (mean age, 45 years +/- 5 [standard deviation]; 10 men) s

51 nts with PCR-confirmed SARS-CoV-2 infection (mean age 46 years, 56% male, 38% with comorbidities).

52 Seventy-eight patients with Fabry disease (mean age, 46 years +/- 14 [standard deviation]; 63% fema

53 24 healthy participants (15 men and 9 women; mean age, 46.3+/-13.0 years) were included.

54 At screening, of 190 participants (mean age, 47 years; 74% male), 62% reported any past-mon

55 ingdom (5931 valid responders; 49.2% female; mean age, 47.4 years; range, 18-92 years).

56 smoker patients (nine males and six females; mean age: 47.73 +/- 12.18; range 21 to 63 years) with on

57 The eMERGE cohort (mean age 48 +/- 14 years, 58% female) included 45,645 EA

58 data from 187,552 people with hypertension (mean age 48.1 years, 53.5% female) living in 43 low- and

59 These patients were younger (mean age 48.3 [standard deviation 14.2]-vs.-55.0 [13.3],

60 es]) revealed PDT era patients were of older mean age (48.9 vs. 53.8 years, P = 0.002) and were more

61 Among 347 356 patients (mean age, 48 [SD, 11] years; 66% women) who underwent su

62 MRI scans from 178 patients (mean age, 48 years +/- 17; 106 women) were used to suppl

63 e analysis, 400 MRI scans from 367 patients (mean age, 48 years +/- 18; 214 men) were included.

64 gibility, 48 were excluded and 157 patients (mean age, 48.3 years [SD 12.9]; 73 [46%] male and 84 [54

65 ed, 100 participants met inclusion criteria (mean age, 48.6 years; 41 men).

66 firmed using the swinging flashlight method (mean age 49.6 years) and 50 healthy control subjects (me

67 A total of 20 adult participants (mean age, 49 years +/- 17 [standard deviation]; 18 men a

68 ed twenty-three patients (85 male/38 female; mean age, 49.5 +/- 13.1 y old) were biopsied after the d

69 sess the impact of stepping down medication: mean age 50.4 years, 39.4% males, 39,881 stepped down.

70 wed from midlife (baseline from1972 to 1987; mean age 50.4 years; 62.1% female) to late life (1998),

71 Thirty lesions from 28 women (mean age, 50 years +/- 13 [standard deviation]) were eva

72 d with those in 10 healthy control subjects (mean age, 50.3 years +/- 17.2).

73 Twenty-seven patients (21 men and 6 women; mean age, 50.3+/-6.3 years) with mild hypertension and w

74 alyzed (mean WON diameter = 14 cm, 64% male, mean age = 51 years) across 3 centers.

75 ion]; 21 part-solid nodules) in 42 patients (mean age, 51 years +/- 17; 21 men and 21 women).

76 Thirty women (mean age, 51.1 years +/- 10.1 [standard deviation]; age

77 Data in a total of 45 patients with glioma (mean age, 51.3 years +/- 14.3 [standard deviation]) were

78 ies (LMICs) and 40,795 people with diabetes (mean age 52.2 years, 57.7% female) living in 28 LMICs on

79 oke patients studied at 2 weeks post-injury (mean age 52.8 years, range 22-77; 63 females; 64 right h

80 Seven trials involving 1,676 participants (mean age = 52.6 years) showed significant improvement in

81 In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%-62.3% in 12

82 st 1 visit in the extension study (62% male; mean age, 52 years).

83 Our study included 903 eFHS participants (mean age 53+/-9 years, 61% women, 9% non-White) who wore

84 ,042 U.S. adults (58.5% female; 89.4% white; mean age = 54.7 years) composed our primary prevention p

85 = ~40,000, aged 40-69 years when recruited, mean age = 54.9), we test for signatures of loneliness i

86 ,190 adult participants (402 female [33.8%]; mean age, 54 y [range 20 to 89+]; 70.6% European) had wh

87 Results A total of 418 041 women (mean age, 54 years +/- 10 [standard deviation]) were inc

88 ancers were sampled from 9376 healthy women (mean age, 54 years +/- 10 [standard deviation]).

89 Results Twenty-five patients (mean age, 54 years +/- 18 [standard deviation]; 13 men)

90 Data from 354 patients (mean age 55 +/- 14 yr, 28.5% male, median admission Glas

91 hundred thirty-four patients were included (mean age, 55 years +/- 11 [standard deviation]; 208 men)

92 90], 7 female), and 20 patients without IBD (mean age 56 [22-88] y, 11 female), were included.

93 with type 2 diabetes (21 936 [48.7%] female; mean age 56.7 years [SD 13.8]) were enrolled in the DCSS

94 -2007, 7,091 insulin-naive Chinese patients (mean age 56.8 +/- 13.3 [SD] years; mean age of T2D onset

95 Among participants (47.5% male, mean age 56.9 years), 6293 developed AF during a median

96 lts One hundred fourteen study participants (mean age, 56 years +/- 15 [standard deviation]; 66 women

97 (2116 participants; 1068 men and 1048 women; mean age, 56 years +/- 8) had no emphysema at CT.

98 e data of 24 patients (18 men and six women; mean age, 56.8 years +/- 11.8 [standard deviation]) susp

99 A total of 4840 participants (mean age, 56.8 years; 2435 [54%] women; 1732 [36%] indiv

100 (n=2) perfusion defects were observed (M=20; mean age=56 +/-8.7 years).

101 (1979 participants; 1096 men and 883 women; mean age, 57 years +/- 8 [standard deviation]) had trace

102 derwent mt-sDNA screening and 9656 patients (mean age, 57 years +/- 8; 5200 women) underwent CT colon

103 d of 99 582 DM examinations in 55 086 women (mean age, 57.3 years +/- 11.6 [standard deviation]).

104 y population included 5 342 207 individuals (mean age, 57.6 [SD, 17.4] years, 93.9% men, 72.5% White

105 Forty-five adult patients (31 men; mean age, 58 years +/- 12 [standard deviation]; 15 patie

106 , we included 1121 COVID-19 positive adults (mean age 59+/-18 years, 59% male) from two academic hosp

107 metric hearing thresholds among 3,135 women (mean age = 59 years) in the Nurses' Health Study II (201

108 Results Sixty-one consecutive patients (mean age, 59 years +/- 11 [standard deviation]; 35 women

109 sing the electronic medical record (n = 326; mean age, 59 years +/-17 [standard deviation]; male-to-f

110 Among the 840 participants who enrolled (mean age, 59.3 years [SD, 8.6 years]; 60% female; 76.8%

111 Among 22,756 participants (mean age 60 +/- 13 years, 53% women), HF occurred in 2,0

112 dy of 10 healthy subjects (controls; 7 male; mean age, 60 +/- 15 years; mean body mass index, 25 +/-

113 Results Forty-five participants (mean age, 60 years +/- 13 [standard deviation]; all wome

114 Among 1 537 101 survivors (mean age, 60.4 years; 48.8% women), 156 442 SPC cases an

115 al of 156 patients (61 males and 95 females; mean age: 60.9 +/- 11.6 years) with 315 implants inserte

116 ncluded 944 consecutive patients with STEMI (mean age 61 years, 209 women) undergoing primary percuta

117 , 30 kg/m(2) +/- 6), and 20 HC participants (mean age, 61 years +/- 10; 55% men; mean BMI, 27 kg/m(2)

118 etrospective study, a total of 145 patients (mean age, 61 years +/- 14 [standard deviation {SD}]; 68

119 tients with Parkinson's disease (19 females, mean age 62, mean Hoehn and Yahr stage 2.6) were assesse

120 y patients were included in the e-HRT group (mean age 62.1 +/- 12.0 years; mean duration of HRT 5.3 +

121 3 +/- 4.5 years) and 80 in the no-HRT group (mean age 62.2 +/- 12 years).

122 this cross-sectional study, 50 participants (mean age 62.5 +/- 11.7 years) without cardiovascular dis

123 r diagnosed with T2DM between 1990 and 2017 (mean age 62.7 years, 55.2% male); 93% were of white ethn

124 The sample (N = 459, Mean age = 62.43, 58.40% female) was a subset of individ

125 Among the 2,264 participants (mean age = 62.6 years), the geometric mean of 25OHD conc

126 t a major hepatic resection were randomized (mean age = 62.8 years; 57% male; body-mass-index = 27.9)

127 nd 30 control subjects (18 men and 12 women; mean age, 62 +/- 10.3 y).

128 al of 2060 patients (5806 chest radiographs; mean age, 62 years +/- 16 [standard deviation]; 1059 men

129 336 patients were randomly assigned (mean age, 62 years [SD, 9]; 68% men; disease duration, 0

130 Among 352 patients randomized (mean age, 62.2 [SD, 17.7] years; 121 women [34.4%]), 345

131 ients with a diagnosis of achalasia (7 male; mean age, 63 +/- 13 years; mean body mass index, 26 +/-

132 p 2 comprised 57 patients (28 men, 29 women; mean age, 63 years +/- 16).

133 ive study included 705 consecutive patients (mean age, 63 years; range, 18-95 years) with proven PE.

134 From March 2015 to April 2016, 97 patients (mean age, 63.9 years; 35% women) were randomly assigned,

135 The final population comprised 120 patients (mean age 64 +/- 16 years, 78 men), of whom 39 (32.5%) ex

136 Results A total of 94 study participants (mean age, 64 years +/- 11 [standard deviation]; 61 men)

137 a and 3148 patients (5300 chest radiographs; mean age, 64 years +/- 18; 1578 men) with non-COVID-19 p

138 od, 196 patients without COVID-19 infection (mean age, 64 years +/- 19; 52% men) with invasive mechan

139 A total of 3987 asymptomatic adult patients (mean age, 64 years +/- 9 [standard deviation]; 2567 wome

140 kg/m(2) +/- 5), 20 participants without DPN (mean age, 64 years +/- 9; 55% men; mean BMI, 30 kg/m(2)

141 Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml

142 e cohort consisted of 2 groups: 47 patients (mean age, 64.2 y old) who underwent Glu-NH-CO-NH-Lys-(Ah

143 Among 3891 participants (mean age 65 +/- 11 y; 55% women; 35% nonwhite), there we

144 The survey was completed by 2,961 patients (mean age 65.1 years, standard deviation 11.7 years), mos

145 ndergoing an anterior approach were younger (mean age, 65 vs 67 years; standardized difference, 0.17)

146 x (BMI).ResultsTwenty participants with DPN (mean age, 65 years +/- 9 [standard deviation]; 70% men;

147 hort who had 3 ceramides measured (n = 1561, mean age 66 y, 59% women).

148 ith mild to moderate PD (23 men and 7 women; mean age, 66 +/- 6.2 y; disease duration, 6.4 +/- 4.0 y;

149 593 vessel segments from 5,947 participants (mean age 67.6 years, SD 7.6 years, 57% women) were inclu

150 p 1 comprised 62 patients (31 men, 31 women; mean age, 67 years +/-17 [standard deviation]), and grou

151 ed cardiac MRI studies done in 120 patients (mean age, 67+/-11.6 years; 88 men) with suspected ischem

152 Among 638 patients randomized, 596 (93.4%) (mean age, 67.5 years; 183 [30.7%] women) completed the t

153 3, 2010, to Dec 28, 2012, 2921 participants (mean age 68.4 years [SD 8.6], 1080 [37%] women) who had

154 t 2019, 105 patients were randomly assigned: mean age 68.7 (SD, 11.1) years, 77 (73.3%) male, 82 (78.

155 Among 826 patients enrolled (mean age, 68 [SD, 7] years; 91 women [12%]), 775 (94%) c

156 Results A total of 307 patients (mean age, 68 years +/- 11 [standard deviation]; 192 men)

157 Among 330 patients who were randomized (mean age, 68 years; 181 [55%] women), 320 (97%) were inc

158 Results A total of 171 participants (mean age, 69 years +/- 8; 111 men) were evaluated.

159 SEMS were placed in 113 patients (73 men; mean age, 69); a single stent was inserted in 106 patien

160 Twenty-three participants (mean age, 69.8 years; 73.9% male; mean furosemide dose,

161 ermediate- or high-risk PC, and 57 patients (mean age, 70.5 y old) who underwent (68)Ga-PSMA11 PET/CT

162 Among 1818 decedents (mean age, 70.8 [SD, 14.7] years; 41% women), 401 (22%) h

163 atients with HF with 5,839 hospitalizations (mean age 71.1 +/- 12.7 years; 47.7% female).

164 A total of 263,480 eyes were included, with mean age 71.4 +/- 11.7 years.

165 Of 150, 97 underwent PET; 22 of the 97 (mean age, 71 years +/- 6; 13 women) were positive for be

166 A total of 50 patients (mean age 72 years old; 52% male) were enrolled.

167 Results One hundred three patients (mean age, 72 years +/- 11 [standard deviation]; 81 men)

168 Of 44 PAD participants randomized (mean age, 72.3 years [+/-7.1]; mean ankle brachial index

169 prescribing episodes (34,074 clarithromycin, mean age 73 years, 42% male; 171,153 amoxicillin, mean a

170 A total of 1079 patients (857 ViV, 222 ViR; mean age 73.5+/-12.5 years; 40.8% male) from 90 centers

171 he explant cohort was significantly younger (mean age 73.7 years vs. 81.7 years), with a lower preval

172 Results A total of 100 participants with AD (mean age, 73 years +/- 9 [standard deviation]; 58 women)

173 women) and 100 age-matched HC participants (mean age, 73 years +/- 9; 60 women) were evaluated.

174 age 73 years, 42% male; 171,153 amoxicillin, mean age 74 years, 45% male).

175 itutionalized adults aged 65 years or older (mean age 74 years, 59% females) endorsing at least one d

176 in amyloid cardiomyopathy and heart failure (mean age, 74.5 years) using inputs from the ATTR-ACT tri

177 five studies were identified (2992 patients; mean age, 76.8 years +/- 6.0 [standard deviation]; 66% f

178 212 patients (mean age 77 +/- 6 years) were included.

179 We included 2181 patients (50.4% men; mean age, 77 years) with aortic valve area <1.3 cm(2) an

180 st follow-up, 36% ambulated with assistance (mean age: 8.9 +/- 6.4 years, SD) and 54% were wheelchair

181 including 4949 patients who underwent TAVR (mean age, 81+/-8 years, mean Society of Thoracic Surgeon

182 The mean age at appointment was 42.9 years old.

183 population-based cohort studies (1983-2018; mean age at baseline = 46 years; median follow-up, 19 ye

184 llow-up, 462 individuals developed dementia (mean age at baseline = 57.5 +/- 5.9 years, 58% women).

185 mation and no history of CVD and cancer, the mean age at baseline was 50.9 (SD 10.4) years, and 40.8%

186 , and in a cohort of n = 64 preterm infants (mean age at birth = 32.0 weeks), we tested whether corti

187 ng (MRI) in n = 292 healthy newborn infants (mean age at birth = 39.9 weeks) with regional patterns o

188 Mean age at cirrhosis evaluation was 62.

189 opsy cases with cerebral amyloid angiopathy (mean age at death 73 years, nine males) and three contro

190 th 73 years, nine males) and three controls (mean age at death 91 years, one male) were included in t

191 The mean age at diagnosis was 40.2 years of age for episcler

192 Two hundred sixty patients were identified (mean age at diagnosis was 68 years and 49% were females)

193 In these R337H+ cases a lower mean age at diagnosis was observed when compared to the

194 The mean age at diagnosis was younger for PTC-T (19.8 years

195 we identified 1699 cases of cardiomyopathy (mean age at diagnosis, 46.2 [SD 9.1] years) during the f

196 ts and Main Results: For all 4,240 subjects, mean age at follow up was 65.4 years, 3,486 (82.0%) were

197 We examined the mean age at HCV-associated death, and rates and proporti

198 Mean age at initial surgery was 5 months (range, 5 days-

199 15 months (range; 5 months-14 years) and the mean age at last visit was 11.3 +/- 6.5 years.

200 onset and at death of their parents and the mean age at onset and at death of their family members.

201 Mean age at onset of late reactivation was 25.6 years (r

202 The mean age at RIS diagnosis was 37.2 years (range, 11-74 y

203 Eighty-seven eyes of 80 patients with a mean age at surgery of 68.9+/-7.03 years were included.

204 The mean age at surgery was 148 +/- 93 days (range 30-359 da

205 cohort included 24 patients (20 [83%] male, mean age for all patients at death, 75.4 +/- 10.0 y).

206 The mean age (% male) was 44.1 (45%) for patients with Fabry

207 2 consecutive patients were recruited with a mean +/- age of 14.7 +/- 2.77 years (range: 8-18 years);

208 ients (42%) had end stage renal disease at a mean age of 10.6 years (6.5-17 years).

209 years old) met our inclusion criteria with a mean age of 13.4 years at bone marrow transplantation.

210 The 4 male patients had a mean age of 26 years (range, 21-32), with no history of

211 This study included 25,623,479 women, with a mean age of 29 years (range 20-50 years); 13,742,486 (53

212 [84%] of 766) and white (560 [73%]), with a mean age of 35.2 years (SD 10.6).

213 subsequently diagnosed with strabismus at a mean age of 4.5 years (range: 1.3 to 8.7 years) (7 with

214 The majority were male (73.4%) and had a mean age of 43.7 years.

215 raphic details for study participants were a mean age of 43.80 years, 47% male and 53% female, 38.5%

216 This study included 16 patients with a mean age of 47.9 +/- 14.7 years, 50% were women, and 25%

217 of 92 eyes of 47 patients (31 females) with mean age of 48.0 +/- 18.0 years and mean follow-up of 78

218 n, of which 1,847 had 1-year follow-up data (mean age of 51 years, mean initial BMI 47.2 kg/m2, and 6

219 We enrolled 156 patients with a mean age of 56 years; 78 patients were assigned to each

220 A total of 464 patients were analyzed (mean age of 56.4 years, 82.5% male, mean duration with H

221 Patients with HFrEF, mean age of 57 years, mean left-ventricular ejection fra

222 .9% identified as non-Hispanic black, with a mean age of 57.7 years, and the mean eGFR is 44.9 ml/min

223 Participants in this ancillary study had a mean age of 58 years and 41% were black; the median eGFR

224 hite, 8% Black, and 3% other/refused, with a mean age of 58 years.

225 A total of 405 patients at a mean age of 60 +/- 13 years in whom chronic oGVHD was di

226 A total of 266 patients, 78.2% males, with a mean age of 60.8+/-11.3 years, were enrolled.

227 Patients had a mean age of 62.0 years (SD, 15.8), with 69.7% male, and

228 with elevated CSF phosphorylated tau levels, mean age of 62.705 +/- 4.628 years), from the population

229 otal of 606 patients (67%) were male, with a mean age of 65+/-11 years.

230 The study population had a mean age of 67.5+/-15.2 years, including 37.2% women.

231 ne 2019, 532 participants (211 women) with a mean age of 69 years +/- 14 (standard deviation) were en

232 total of 1001 patients were enrolled, with a mean age of 73.7 years and 598 (59%) male.

233 d were 11 397 eyes of 11 397 patients with a mean age of 75.4 +/- 8.3 years (62.5% women).

234 nd 36 subjects (11 males, 25 females) with a mean age of 81.00 +/- 5.5 years in the control group.

235 re 42 patients (14 males, 28 females) with a mean age of 81.10 +/- 6.3 years in the kyphosis group an

236 The mean age of individuals in groups 1, 2, and 3 were 55.2,

237 The mean age of patients was 49.52 +/- 8.83 years.

238 patients (mean age 56.8 +/- 13.3 [SD] years; mean age of T2D onset 51.1 +/- 12.7 years; 47% men; 28.4

239 Mean age of the patients was 48.2 years (range, 25-75 ye

240 The mean age of the study cohort was 53.1 years, and 42 (56.

241 The difference between the mean age of the two groups was not significant.

242 Mean ages ranged from 10.2 to 19.5 years.

243 The mean age (SD) was 46.1 (17.2) years, 109 (60.2%) were ma

244 hundred thirteen eyes of 409 patients with a mean age +/- standard deviation (SD) of 70.2 +/- 9.8 yea

245 The mean age +/- standard deviation (SD) of the patients was

246 Survivors (mean age +/- standard deviation [SD], 35.6 +/- 8.8 years

247 Among the 904 participants, baseline mean age +/- standard deviation was 14.0 +/- 1.5 years,

248 Results Seventeen participants (mean age +/- standard deviation, 13 years +/- 5; nine ma

249 ults A total of 52 participants with NMOSDs (mean age +/- standard deviation, 44 years +/- 15; 45 wom

250 ssessed symptoms in 172 patients (66% women; mean age +/- standard deviation, 45 +/- 12 years; 133 wi

251 evaluated: 20 healthy control participants (mean age +/- standard deviation, 56 years +/- 11; 11 wom

252 esultsA total of 7143 COPDGene participants (mean age +/- standard deviation, 59.8 years +/- 8.9; 373

253 Among 316,840 participants, the mean age +/- standard error was 46.9 +/- 0.1 years, 52%

254 ocognitive assessment, 55% were male and the mean age was 22.6 years (SD 7.8).

255 Mean age was 29 years; 77% attended college; 75% were si

256 The mean age was 34 +/- 14 years and the mean logarithm of m

257 The mean age was 35.5 years, 79% were male and 82% were whit

258 Mean age was 38 (SD+/-10) years, 58 (57%) were female an

259 Mean age was 39.4 years (SD +/- 12.0) and 69.1% (n = 392

260 The mean age was 40 years.

261 Mean age was 40.5 years.

262 Mean age was 41.2 +/- 13.1 years, 59.5% were women, 25.5

263 The mean age was 41.6 years (SD 12.6), mean viral load at ba

264 Mean age was 42 years (range, 24-73 years); 69% were BRC

265 Mean age was 42.00 +/- 5.48 years, with average follow-u

266 In a total of 501 subjects (1002 eyes), the mean age was 43.12 +/- 18.80 years and 347(69.3%) were f

267 ere included, of which 69.6% were women, the mean age was 45.8 years (SD 11.5), the mean baseline BMI

268 The mean age was 46+/-18 years; 55% were women.

269 ndetectable viral load; 64 (86%) were black; mean age was 49 +/- 8 years.

270 The mean age was 49.4 years, 64% women were non-Hispanic bla

271 286 patients were included; the mean age was 51.4 years (SD, 14.4), 25.9% were female, a

272 In 22 patients, the mean age was 52.3 +/- 11 years (range 18-71 years) with

273 Mean age was 53 years, 45% female, 80% White, and 36% ha

274 ts and Main Results: Among 336 subjects, the mean age was 53.1 (SD, 9.9) years.

275 The mean age was 54 years (SD = 14; range 18-89) and 54% had

276 Their mean age was 54 years, and 58% were women.

277 In the combined datasets, mean age was 54.8 +/- 15.9 years for the HCM group and 5

278 Mean age was 56 years and 34.1% were men.

279 patients were black (64%) and men (56%); the mean age was 56 years.

280 The mean age was 56.6 +/- 15.1 years and 67 (66.3%) were men

281 393,193 and 441,016 individuals in whom the mean age was 56.9 y (range 39-73 y) and of whom 54.2% we

282 The mean age was 57 years, 65% were male, and 28% were Hispa

283 Mean age was 57.2 +/- 12.6 years, BMI 33.7 +/- 11.4 kg/m

284 The mean age was 59 years (range 36-73), and 25 (83%) of 30

285 Mean age was 60 (13) years old and 66% were males.

286 The mean age was 60.3 years (32-86 years; 9m/8f) and the fol

287 Two hundred eighty patients were included, mean age was 60.9 years and 68.9% were male.

288 Of the remaining 531 patients, the mean age was 61.0 years (+/- 17.6 yr), 281 were females

289 otal of 755 patients were evaluable, and the mean age was 62.3 +/- 9.5 years, 31% were women, 55% had

290 Mean age was 63 years and 205 patients (67.2%) were male

291 Mean age was 63.5 years, and 45% were women.

292 The mean age was 67.8 years, 55.5% were men, mean baseline c

293 Mean age was 67.8 years.

294 Mean age was 68.9 years, 48% were female, and 64% were W

295 The mean age was 69.3 years (10.5 yr), 119 were men (66.1%).

296 Mean age was 74 years, with a median type 2 diabetes dur

297 The mean age was 74.4 years (standard deviation:8.7 years);

298 Mean age was 8.9+/-5.8 years (range, 29 days to 18 years

299 Participants' mean age was 81.5 years, 44.4% were women, and 10.5% wer

300 Mean age was 83.5 (SD, 8.5) years in cohort 1, 69.1 (SD,